This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Shinkei (2014-10-10)

Starting date:
October 10, 2014
Posting date:
April 16, 2015
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-52953

Recalled Products

Shinkei

Reason

Product was sold without a valid market authorization and label claim indicated relief of menopausal symptoms. The product was not labelled in official language (English or French).

Depth of distribution

Retailers, Distributor

Affected products

Shinkei

DIN, NPN, DIN-HIM
No market authorization
Dosage form

Tablet

Strength
  • 1,2,3,5/4,6- hexahydroxycyclohexane 40.0 mg
  • Angelica acutiloba 40.0 mg
  • Cnidium monnierie 40.0 mg
  • Paeonia lactiflora 44.0 mg
  • Rehmannia glutinosa 40.0 mg
  • Vitamin B12 10.0 mcg
Lot or serial number

LXWK

Companies
Recalling Firm
SciQReg Consulting (On behalf of Sato Pharmaceutical Canada Inc.)
201-4990 McGeer Street
Vancouver
V5R 6C1
British Columbia
CANADA
Marketing Authorization Holder
N/A

Date modified: